Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

Gilead Sciences: 4 Reasons This Stock Has Much More To Rise

Gilead Pharmaceuticals is back to highs not seen in a decade as its HIV treatment franchise surges and awaits its 100% effective HIV prevention drug in summer

SolarEdge: A Surprising Bright Spot in a Troubled Solar Industry?

SolarEdge: A Surprising Bright Spot in a Troubled Solar Industry?

SolarEdge Technologies defied the industry downturn with a revenue beat and positive free cash flow, prompting a rally and turn-around discussion.

MarketBeat Week in Review – 02/17 - 02/21

Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom

With NVIDIA delivering more growth this year, three stocks could benefit greatly from its success, with more upside of their own.

MercadoLibre: High-Growth EM Stock With 100% Upside Potential

MercadoLibre is Latin America's leading eCommerce platform and is on track to see its share price rise by at least 100% within the next two to three years.

As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum

After two years of strong gains from the Magnificent 7, the rotation trade is gaining steam; here are three stocks for growth-oriented investors to consider

Gold's Ascent: Can Miners and ETFs Take Investors to $3,000?

Geopolitical forces, economic shifts, and central bank actions are fueling a gold surge, creating investment options through mining stocks and ETFs.

inkl

Read news from The Economist, FT, and more,
with one subscription

Medtronic’s Expansion Gains Momentum—Time for a Market Shift?

Medtronic’s Expansion Gains Momentum—Time for a Market Shift?

Medtronic is on track to complete a market reversal later this year as investments in technology and innovation begin to pay off.

These 4 Low P/E Tech Stocks Could be Breakout-Ready Bargains

These 4 Low P/E Tech Stocks Could be Breakout-Ready Bargains

This article introduces four high-tech stock picks that feature P/E ratios less than 20 and positive analyst estimates for share price.

Palantir Stock Skids—How Much Further Can It Fall?

Palantir Stock Skids—How Much Further Can It Fall?

PLTR stock is down more than 17%; investors wonder if the stock is setting up for a knock-out blow or if it can get up off the map and surge higher

2 S&P 500 ETFs for Growth and Leverage in a Hot Market

2 S&P 500 ETFs for Growth and Leverage in a Hot Market

With the great returns of the S&P 500 in recent months, investors looking for something more from the index have two trending ETFs to consider.

Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?

Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?

Recursion Pharmaceuticals' stock has soared due to Nvidia's continued investment, positioning the company as a leader in AI-driven drug discovery.

Garmin’s Growth Signals Wearables Surge: Stocks to Watch

Garmin’s Growth Signals Wearables Surge: Stocks to Watch

Consumer technology companies are outperforming in 2025 as demand for wearables increases. Market-leading Garmin's stock price hits new highs.

3 Precious Metals ETFs Gaining Big as Gold Nears New Highs

3 Precious Metals ETFs Gaining Big as Gold Nears New Highs

Precious metals have surged, with gold seeing all-time highs this year; these three ETFs can help to provide easy exposure to the rally.

Get all your
news in one place.

100’s of premium titles.
One news app.

These 3 Defensive Retail Stocks Are Outpacing the Market

Recent economic data shows investors that a potential rotation out of cyclical names is starting, one that could benefit these defensive stocks.

Ray Dalio's Bridgewater Loaded Up on These Stocks in Q4 2024

Bridgewater Associates, the investment management company founded by Ray Dalio 50 years ago, just invested millions in these three stocks.

Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive

Walmart got the market's attention with weaker-than-expected guidance, and warning tariffs would impact the business, but this price dip isn't a signal to sell.

Tesla: 2 Reasons to Buy, 1 Reason to Run

With bullish analysts calling for 45% upside, momentum is clearly starting to swing away from the bears and back to the bulls.

Get all your
news in one place.

100’s of premium titles.
One news app.

Should You Hold NVIDIA Stock for the Long Haul or Trade It?

Nvidia stock might be the best opportunity for both investors and traders alike. This mix is as uncommon as the upside in the name.

Humana Gains Despite Medicare Advantage Losses—What’s the Catch?

Humana is the second largest health insurance provider of Medicare Advantage (MA) plans sounding the alarms of rising medical costs but will now cut 10%

Buybacks Galore: 3 Mega-Caps Just Approved Billions in Buybacks

Check out these three mega-cap names, valued over $200 billion each, that just authorized a combined $28 billion in buybacks.

3 Beauty Stocks Off to an Ugly Start—Can 1 Stage a Comeback?

Beauty stocks are off to an ugly start in 2025, but there may be 1 stock that will lead the rebound as they already beat and raised earnings guidance.

Fastenal : Growth Trends, Challenges & Key Investment Insights

Fasteners, bolts, screws and studs may seem like a boring business, but its big business for Fastenal which may see sales surge in the "Golden Age" of manufact

2 Auto Stocks to Let Go and 1 Worth Buying for the Long Haul

As retail sales data comes out for investors to digest and analyze, it becomes clear that the theme favors one stock in the automotive sector.

Biogen Stock Is Mutating Into a Value Play

Biogen shares have fallen over 70% from its highs nearly 12-years ago, but value investors should take a look at its metrics of just 12.4 P/E and P/B of 1.2X

1 … 84 85 86 87

People

138,361 stories

Gabriel OsorioMazilli

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

301,995 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play